Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

L. Vasanthamohan, Thomas DeLoughery

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy'. Together they form a unique fingerprint.